Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Immunoprecise Antibodies Ltd
IPA
Technology
Scientific & Technical Instruments
ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, and others. The majority of its revenue is derived from the United...
States of America.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:IPA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(36)
•••
wallpaper2
X
View Profile
View Bullboard History
Post by
wallpaper2
on Oct 27, 2023 12:38pm
You have 2 weeks. Fwiw.
AGM is Nov 9th and 2 or 3 more highly experienced and recognizable industry leaders will replace the remaing 2 original directors. This company appears to possess the ticket to success and wealth
...more
(36)
•••
wallpaper2
X
View Profile
View Bullboard History
Post by
wallpaper2
on Oct 25, 2023 10:23am
Todays game changing news release.
There are many many AI upstart companies out there, but none can touch what Biostrand/Hyft now offer. IPA described their $25 million purchase of Biostrand as "The Aquisition of the
...more
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net
posted May 02, 2024 9:00am by
Xcyte Digital Corp.
-
|
"The addition of Webinar.net further enhances Xcyte's suite of solutions by adding a technology platform that was built for and hosted on the cloud with enterprise grade scale and security. Webinar.net infrastructure is built to handle millions of online presentation attendees from global businesses. This acquisition further enhances our revenue and EBITDA growth in alignment with our medium-term expansion objectives ...read more
(36)
•••
wallpaper2
X
View Profile
View Bullboard History
Post by
wallpaper2
on Oct 23, 2023 12:21pm
Dart
You were the self appointed expert on MLCL and posted around 1000X per year. It is bankrupt and HALTED at .005 cents and you predicted dollar$ . IPA wil see $5-$20/share before it ever
...more
(541)
•••
dart321
X
View Profile
View Bullboard History
Post by
dart321
on Oct 11, 2023 12:29pm
Pink Sheets
This is heading to the pink sheets real soon !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(36)
•••
wallpaper2
X
View Profile
View Bullboard History
Post by
wallpaper2
on Aug 12, 2023 12:43am
Dart
Out of money by friday in May? A lot of idiots out there. June saw a 47% increase over last June with revenue of $3.5 million. How does that stack up against your mlcl? Doesn't include their
...more
(49)
•••
bmreed
X
View Profile
View Bullboard History
Post by
bmreed
on Jul 26, 2023 5:10pm
Webinar Recap w $IPA CEO Jennifer Bath & Radius Research
Webinar Recap: Immunoprecise Antibodies $IPA w CEO Jennifer Bath - Pitch, Deep Dive and Q&A - https://youtu.be/WJhkiouXF1c CEO Jennifer Bath discusses IPA's technology platform
...more
(49)
•••
bmreed
X
View Profile
View Bullboard History
Post by
bmreed
on Jul 14, 2023 2:47pm
Webinar $IPA CEO Jennifer Bath Wed Jul 19 @ 4PM ET / 1PM PT
Webinar - IPA Therapeutics $IPA w/ CEO Jennifer Bath Wednesday, July 19th at 4pm ET / 1pm PT Q&A with Radius Research Register Here - https://us02web.zoom.us/webinar/register
...more
(9)
•••
averagepennies
X
View Profile
View Bullboard History
Post by
averagepennies
on Jul 14, 2023 9:33am
ImmunoPrecise Antibodies Invites Investors and Stakeholders
VICTORIA, British Columbia--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) ("IPA" or the "Company"), an AI-driven biotherapeutic research and technology, is delighted
...more
(9)
•••
averagepennies
X
View Profile
View Bullboard History
Post by
averagepennies
on Jul 07, 2023 9:13am
ImmunoPrecise Reports Financial Results and Recent Business
The Company achieved revenue of $20.7 million during the year ended April 30, 2023, a 6.7% increase from the year ended April 30, 2022. YoY growth increases to 9.0% when adjusting for the effects of
...more
(29)
•••
AveragePenny
X
View Profile
View Bullboard History
Post by
AveragePenny
on Jun 29, 2023 9:42am
IPA to Report Financial Results and Recent Business
Conference Call: Event Date: July 07, 2023 Event Time: 10:30 ET Participant Details: Conference ID: 9236374 Participant Toll-Free Dial-In Number: 1 (888) 550-5658 Participant Toll Dial-In
...more
(29)
•••
AveragePenny
X
View Profile
View Bullboard History
Post by
AveragePenny
on Jun 13, 2023 11:57am
IPA’s Subsidiary BioStrand Unveils Use Case for Solving
VICTORIA, British Columbia--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a leader in AI-driven biotherapeutic research and technology, is excited to announce
...more
(29)
•••
AveragePenny
X
View Profile
View Bullboard History
Post by
AveragePenny
on Jun 06, 2023 11:20am
IPA Releases New HYFT-Powered In Silico Humanization
VICTORIA, British Columbia--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”) today introduced a transformative AI-driven rapid therapeutic screening platform, the
...more
(29)
•••
AveragePenny
X
View Profile
View Bullboard History
Post by
AveragePenny
on May 30, 2023 10:03am
IPA's Subsidiary, BioStrand, Solves the Information
VICTORIA, British Columbia--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“ImmunoPrecise” or “IPA” or the “Company”), an AI-driven biotherapeutic research and technology company, today
...more
(29)
•••
AveragePenny
X
View Profile
View Bullboard History
Post by
AveragePenny
on May 17, 2023 11:19am
IPA to Present at Jefferies Healthcare Conference 2023
VICTORIA, British Columbia--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“ImmunoPrecise” or “IPA” or the “Company”) an AI-driven biotherapeutic research and technology company today
...more
(541)
•••
dart321
X
View Profile
View Bullboard History
Post by
dart321
on May 15, 2023 11:31am
Running out of money
as per their financials they will be out of cash in 30 days, by the trading friday and today it looks like the institutions are jumping off the band wagon.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up
Mullen Group Ltd. Reports 2024 First Quarter Financial Results
Significant New Silver Discoveries in the Famous Keno Hill District in the Yukon
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company